Trial intelligence / Profile preview

Desloratadine in Japanese subjects with seasonal allergic rhinitis

NCT02320396Phase 3Completed

Sponsor
Organon & Co.
Start
Jan 2015
Primary completion
Apr 2015
Modality
Small Molecules
01

Overview

A Phase 3 trial of desloratadine in seasonal allergic rhinitis (SAR), sponsored by Organon & Co.. Started Jan 2015; status: completed.

02

Drugs

desloratadine
03

Conditions

seasonal allergic rhinitis (SAR)

Beyond the preview

Go deeper on NCT02320396.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02320396.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call